Targeting Tyrosyl-DNA phosphodiesterase I to enhance toxicity of phosphodiester linked DNA-adducts

Abstract

Our genomic DNA is under constant assault from endogenous and exogenous sources, which needs to be resolved to maintain cellular homeostasis. The eukaryotic DNA repair enzyme Tyrosyl-DNA phosphodiesterase I (Tdp1) catalyzes the hydrolysis of phosphodiester bonds that covalently link adducts to DNA-ends. Tdp1 utilizes two catalytic histidines to resolve a growing list of DNA-adducts. These DNA-adducts can be divided into two groups: small adducts, including oxidized nucleotides, RNA, and non-canonical nucleoside analogs, and large adducts, such as (drug-stabilized) topoisomerase- DNA covalent complexes or failed Schiff base reactions as occur between PARP1 and DNA. Many Tdp1 substrates are generated by chemotherapeutics linking Tdp1 to cancer drug resistance, making a compelling argument to develop small molecules that target Tdp1 as potential novel therapeutic agents. Tdp1’s unique catalytic cycle, which is centered on the formation of Tdp1-DNA covalent reaction intermediate, allows for two principally different targeting strategies: (1) catalytic inhibition of Tdp1 catalysis to prevent Tdp1-mediated repair of DNA-adducts that enhances the effectivity of chemotherapeutics; and (2) poisoning of Tdp1 by stabilization of the Tdp1- DNA covalent reaction intermediate, which would increase the half-life of a potentially toxic DNA-adduct by preventing its resolution, analogous to topoisomerase targeted poisons such as topotecan or etoposide. The catalytic Tdp1 mutant that forms the molecular basis of the autosomal recessive neurodegenerative disease spinocerebellar ataxia with axonal neuropathy best illustrates this concept; however, no small molecules have been reported for this strategy. Herein, we concisely discuss the development of Tdp1 catalytic inhibitors and their results.

Keywords

Tdp1 / small molecules / DNA topoisomerases / Camptothecins / oxidative DNA damage / DNA adducts / Etoposide / chain terminating nucleotides/nucleoside analogs / DNA metabolism / drug development

References

[1] Interthal H,Champoux JJ.The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily..Proc Natl Acad Sci U S A2001;98:12009-14 PMCID:PMC59758

[2] Pouliot JJ,Robertson CA.Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes..Science1999;286:552-5

[3] Yang SW,Huizenga BN,Yao KC.A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases..Proc Natl Acad Sci U S A1996;93:11534-9 PMCID:PMC38092

[4] Comeaux EQ.Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target..Drug Metab Rev2014;46:494-507

[5] Ben Hassine S.Tdp1 protects against oxidative DNA damage in non-dividing fission yeast..EMBO J2009;28:632-40 PMCID:PMC2666031

[6] Das BB,Maddali K.Role of tyrosyl-DNA phosphodiesterase (TDP1) in mitochondria..Proc Natl Acad Sci U S A2010;107:19790-5 PMCID:PMC2993338

[7] Fam HK,Walton C,Boerkoel CF.Expression profile and mitochondrial colocalization of Tdp1 in peripheral human tissues..J Mol Histol2013;44:481-94

[8] Al Abo M,Liu X,Huang SY.TDP1 is critical for the repair of DNA breaks induced by sapacitabine, a nucleoside also targeting ATM- and BRCA-deficient tumors..Mol Cancer Ther2017;16:2543-51 PMCID:PMC5971110

[9] Alagoz M,El-Khamisy SF.TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy..Nucleic Acids Res2014;42:3089-103 PMCID:PMC3950670

[10] Huang SY,Dalla Rosa I,Naumova A.TDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating anticancer and antiviral nucleoside analogs..Nucleic Acids Res2013;41:7793-803 PMCID:PMC3763526

[11] Interthal H,Champoux JJ.Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages..J Biol Chem2005;280:36518-28 PMCID:PMC1351008

[12] Lebedeva NA,El-Khamisy SF.Tyrosyl-DNA phosphodiesterase 1 initiates repair of apurinic/apyrimidinic sites..Biochimie2012;94:1749-53 PMCID:PMC3778944

[13] Lebedeva NA,Ishchenko AA,Lavrik OI.The mechanism of human tyrosyl-DNA phosphodiesterase 1 in the cleavage of AP site and its synthetic analogs..DNA Repair (Amst)2013;12:1037-42

[14] Lebedeva NA,Lavrik OI.AP-site cleavage activity of tyrosyl-DNA phosphodiesterase 1..FEBS Lett2011;585:683-6

[15] El-Khamisy SF,Caldecott KW.TDP1 facilitates repair of ionizing radiation-induced DNA single-strand breaks..DNA Repair (Amst)2007;6:1485-95

[16] He X,Babaoglu K,Nitiss KC.Mutation of a conserved active site residue converts tyrosyl-DNA phosphodiesterase I into a DNA topoisomerase I-dependent poison..J Mol Biol2007;372:1070-81

[17] Inamdar KV,Zhou T,Rasouli-Nia A.Conversion of phosphoglycolate to phosphate termini on 3’ overhangs of DNA double strand breaks by the human tyrosyl-DNA phosphodiesterase hTdp1..J Biol Chem2002;277:27162-8

[18] Zhou T,Mohapatra S,Valerie K.Tyrosyl-DNA phosphodiesterase and the repair of 3’-phosphoglycolate-terminated DNA double-strand breaks..DNA Repair (Amst)2009;8:901-11 PMCID:PMC2763370

[19] Zhou T,Tatavarthi H,Valerie K.Deficiency in 3’-phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (TDP1)..Nucleic Acids Res2005;33:289-97 PMCID:PMC546157

[20] Murai J,Das BB,Takeda S.Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells..J Biol Chem2012;287:12848-57 PMCID:PMC3339927

[21] Murai J,Das BB,Zhang Y.Trapping of PARP1 and PARP2 by clinical PARP inhibitors..Cancer Res2012;72:5588-99 PMCID:PMC3528345

[22] Murai J,Shahane SA,Huang R.Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platform..DNA Repair (Amst)2014;21:177-82 PMCID:PMC4125495

[23] Prasad R,Dai DP.Repair pathway for PARP-1 DNA-protein crosslinks..DNA Repair (Amst)2019;73:71-7 PMCID:PMC6312470

[24] Barthelmes HU,Christensen MO,Interthal H.TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II..J Biol Chem2004;279:55618-25

[25] Nitiss KC,He X,Nitiss JL.Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage..Proc Natl Acad Sci U S A2006;103:8953-8 PMCID:PMC1482547

[26] Gajewski S,Jafari N,Bashford D.Analysis of the active-site mechanism of tyrosyl-DNA phosphodiesterase I: a member of the phospholipase D superfamily..J Mol Biol2012;415:741-58 PMCID:PMC3265611

[27] Hawkins AJ,Akopiants K,Taylor SM.In vitro complementation of Tdp1 deficiency indicates a stabilized enzyme-DNA adduct from tyrosyl but not glycolate lesions as a consequence of the SCAN1 mutation..DNA Repair (Amst)2009;8:654-63 PMCID:PMC2844109

[28] Interthal H,Kehl-Fie TE,Leppard JB.SCAN1 mutant Tdp1 accumulates the enzyme - DNA intermediate and causes camptothecin hypersensitivity..EMBO J2005;24:2224-33 PMCID:PMC1150888

[29] Takashima H,John J,Salih MA.Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy..Nat Genet2002;32:267-72

[30] Cuya SM,van Waardenburg R.DNA topoisomerase-targeting chemotherapeutics: what’s new?.Cancer Chemother Pharmacol2017;80:1-14

[31] Pouliot JJ,Nash HA.Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae..Genes Cells2001;6:677-87

[32] Raymond AC,Staker B,Burgin AB Jr.Analysis of human tyrosyl-DNA phosphodiesterase I catalytic residues..J Mol Biol2004;338:895-906

[33] Scott P,Al Fahdi A,Bruwer Z.Spinocerebellar ataxia with axonal neuropathy type 1 revisited..J Clin Neurosci2019;67:139-44

[34] Dean RA,An J,Shimizu Y.Identification of a putative Tdp1 inhibitor (CD00509) by in vitro and cell-based assays..J Biomol Screen2014;19:1372-82

[35] Duffy S,Wang YK,Kim JH.Overexpression screens identify conserved dosage chromosome instability genes in yeast and human cancer..Proc Natl Acad Sci U S A2016;113:9967-76 PMCID:PMC5018746

[36] Comeaux EQ,Kojima K,Wanzeck KC.Tyrosyl-DNA phosphodiesterase I catalytic mutants reveal an alternative nucleophile that can catalyze substrate cleavage..J Biol Chem2015;290:6203-14 PMCID:PMC4358259

[37] Cuya SM,Wanzeck K,van Waardenburg RC.Dysregulated human Tyrosyl-DNA phosphodiesterase I acts as cellular toxin..Oncotarget2016;7:86660-74 PMCID:PMC5349943

[38] Hirano R,Huang C,Deguchi K.Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation?.EMBO J2007;26:4732-43 PMCID:PMC2080798

[39] Katyal S,Russell HR,Ju L.TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo..EMBO J2007;26:4720-31 PMCID:PMC2080805

[40] Li J,Nitiss KC,Hanakahi LA.TDP1 is required for efficient non-homologous end joining in human cells..DNA Repair (Amst)2017;60:40-9

[41] El-Khamisy SF,Weinfeld M,Helleday T.Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1..Nature2005;434:108-13

[42] Davies DR,Champoux JJ.Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures..J Mol Biol2002;324:917-32

[43] Davies DR,Champoux JJ.Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide..Chem Biol2003;10:139-47

[44] Davies DR,Champoux JJ.Explorations of peptide and oligonucleotide binding sites of tyrosyl-DNA phosphodiesterase using vanadate complexes..J Med Chem2004;47:829-37

[45] Swarup G,Garbers DL.Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate..Biochem Biophys Res Commun1982;107:1104-9

[46] Liao Z,Jobson A.Inhibition of human tyrosyl-DNA phosphodiesterase by aminoglycoside antibiotics and ribosome inhibitors..Mol Pharmacol2006;70:366-72

[47] Huang SN,Marchand C.Tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibitors..Expert Opin Ther Pat2011;21:1285-92 PMCID:PMC3157054

[48] Huang HC,Baglo Y,Anbil S.Mechanism-informed repurposing of minocycline overcomes resistance to topoisomerase inhibition for peritoneal carcinomatosis..Mol Cancer Ther2018;17:508-20 PMCID:PMC5805648

[49] Chukwudi CU.rRNA binding sites and the molecular mechanism of action of the tetracyclines..Antimicrob Agents Chemother2016;60:4433-41 PMCID:PMC4958212

[50] Antony S,Stephen AG,Agama KK.Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1..Nucleic Acids Res2007;35:4474-84 PMCID:PMC1935015

[51] Banerjee B,Sen N.A tyrosyl DNA phosphodiesterase 1 from kinetoplastid parasite Leishmania donovani (LdTdp1) capable of removing topo I-DNA covalent complexes..Mol Microbiol2010;78:119-37

[52] Keil A,Steiner SK,Schmid RA.The Topoisomerase I inhibitor irinotecan and the Tyrosyl-DNA phosphodiesterase 1 inhibitor furamidine synergistically suppress murine lupus nephritis..Arthritis Rheumatol2015;67:1858-67

[53] Dexheimer TS,Stephen AG,Antony S.4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors..J Med Chem2009;52:7122-31 PMCID:PMC2784989

[54] Marchand C,Jadhav A,Austin CP.Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay..Mol Cancer Ther2009;8:240-8 PMCID:PMC2676116

[55] Sirivolu VR,Marchand C,Chergui A.5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I..J Med Chem2012;55:8671-84

[56] Weidlich IE,Marchand C,Pommier Y.Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores..Bioorg Med Chem2010;18:182-9 PMCID:PMC4123439

[57] Gushchina IV,Zakharenko AL,Svedas VK.Structure modeling of human Tyrosyl-DNA phosphodiesterase 1 and screening for its inhibitors..Acta Naturae2017;9:59-66 PMCID:PMC5509001

[58] Lountos GT,Kiselev E,Needle D.Identification of a ligand binding hot spot and structural motifs replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail screening..Nucleic Acids Res2019;47:10134-50 PMCID:PMC6821334

[59] Das BB,Murai J,Ame JC.PARP1-TDP1 coupling for the repair of topoisomerase I-induced DNA damage..Nucleic Acids Res2014;42:4435-49 PMCID:PMC3985661

[60] Murai J,Renaud A,Ji J.Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib..Mol Cancer Ther2014;13:433-43 PMCID:PMC3946062

[61] Jun JH,Dexheimer TS,Nicklaus MC.Synthesis, anti-cancer screening and tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibition activity of novel piperidinyl sulfamides..Eur J Pharm Sci2018;111:337-48

[62] Zakharenko A,Zhukova S,Zakharova O.Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety..Bioorg Med Chem2015;23:2044-52

[63] Khomenko T,Odarchenko T,Sannikova V.New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties..Bioorg Med Chem2016;24:5573-81

[64] Li-Zhulanov NS,Chepanova AA,Zafar A.A novel class of Tyrosyl-DNA phosphodiesterase 1 inhibitors that contains the octahydro-2H-chromen-4-ol scaffold..Molecules2018;23:E2468 PMCID:PMC6222798

[65] Mozhaitsev ES,Suslov EV,Zakharova OD.Novel inhibitors of DNA repair enzyme TDP1 combining monoterpenoid and adamantane fragments..Anticancer Agents Med Chem2019;19:463-72

[66] Zakharova O,Zakharenko A,Filimonov A.Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors..Bioorg Med Chem2018;26:4470-80

[67] Zakharenko AL,Sokolov DN,Nikolin VP.Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topotesmall es, Cyrillican on in vivo tumor models..Eur J Med Chem2019;161:581-93

[68] Komarova AO,Dyrkheeva NS,Oslovsky VE.Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy..J Enzyme Inhib Med Chem2018;33:1415-29 PMCID:PMC6136360

[69] Salomatina OV,Zakharenko AL,Fadeev DS.Novel semisynthetic derivatives of bile acids as effective Tyrosyl-DNA phosphodiesterase 1 inhibitors..Molecules2018;23:E679 PMCID:PMC6017735

[70] Efremova AS,Shram SI,Drenichev MS.Disaccharide pyrimidine nucleosides and their derivatives: a novel group of cell-penetrating inhibitors of poly(ADP-ribose) polymerase 1..Nucleosides Nucleotides Nucleic Acids2013;32:510-28

[71] Maltseva EA,Sukhanova MV.Poly(ADP-ribose) polymerase 1 modulates interaction of the nucleotide excision repair factor XPC-RAD23B with DNA via Poly(ADP-ribosyl)ation..J Biol Chem2015;290:21811-20 PMCID:PMC4571937

[72] Tian LW,Tran TD,Pfeifer T.Tyrosyl-DNA phosphodiesterase I inhibitors from the Australian plant macropteranthes leichhardtii..J Nat Prod2015;78:1756-60

[73] Tian LW,Tran TD,Pfeifer T.Achyrodimer F, a tyrosyl-DNA phosphodiesterase I inhibitor from an Australian fungus of the family Cortinariaceae..Bioorg Med Chem Lett2017;27:4007-10

[74] Takagi M,Hwang JH,Izumikawa M.Tyrosyl-DNA phosphodiesterase 1 inhibitor from an anamorphic fungus..J Nat Prod2012;75:764-7